Autoimmune pancreatitis – a surgical mistake?
Authors:
L. Havlůj 1; A. Whitley 1; J. Hajer 2; T. Hráček 1; R. Gürlich 1
Authors place of work:
Chirurgická klinika Fakultní nemocnice Královské Vinohrady a 3. lékařské fakulty, Praha
1; Gastrocentrum Fakultní nemocnice Královské Vinohrady a 3. lékařské fakulty, Praha
2
Published in the journal:
Rozhl. Chir., 2022, roč. 101, č. 11, s. 540-544.
Category:
Case Report
doi:
https://doi.org/10.33699/PIS.2022.101.11.540–544
Summary
Autoimmune pancreatitis is a specific type of chronic pancreatitis. Its clinical manifestation mimics pancreatic cancer. A multidisciplinary approach is necessary to establish the correct diagnosis. Autoimmune pancreatitis can be diagnosed on the basis of symptomatology, imaging methods, endoscopy, serology and histopathological examination. There are two different forms of autoimmune pancreatitis – type 1 and type 2. Type 1 is lymphoplasmacytic sclerosing pancreatitis and type 2 is idiopathic centroductal sclerosing pancreatitis. The disease most often takes a chronic form with acute exacerbations. In this paper we present two case reports of patients operated on for suspected malignancy of the pancreas, who were subsequently diagnosed with autoimmune pancreatitis based on histopathological examination. The aim of this communication is to point out the diagnostic pitfalls of this disease. Surgical treatment is not considered as a standard therapeutic method according to the current guidelines.
Keywords:
autoimmune disease – chronic pancreatitis – autoimmune pancreatitis – IgG4
Zdroje
1. Sarles H, Sarles JC, Camatte R, et al. Chronic inflammatory sclerosing of the pancreas – An autonomous pancreatic disease? Am J Dig Dis. 1961;6:688–698. doi:10.1007/BF02232341.
2. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561–1568. doi:10.1007/ BF02285209.
3. Dítě P, Ševčíková A, Novotný I, et al. Autoimunitní chronická pankreatitida. Bulletin HPB 2004;12(3):78–80.
4. Kamisawa T, Shimosegawa T. Epidemiology of autoimmune pancreatitis. Pancreas 2018;503–5099. doi:10.1002/ 9781119188421.ch63.
5. Nishimori I, Tamakoshi A, Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J. Gastroenterol. 2007 May;42(18):6–8. doi:10.1007/s00535-007-2043-y.
6. Okazaki K, Kawa S, Kamisawa T, et al. Japanese clinical guidelines for autoimmune pancreatitis. Pancreas 2009;38(8):849–866. doi:10.1097/MPA. 0b013e3181b9ee1c.
7. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010 Jul; 139(1):140–148;e12–23. doi:10.1053/j.gastro. 2010.03.054.
8. Masood M. Autoimmune pancreatitis: What we know so far. JGH Open. 2021;6(1):3–10. doi:10.1002/jgh3.12688.
9. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009 Nov;58(11):1504–1537. doi:10.1136/ gut.2008.172908.
10. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4(8):1010–1016;934. doi:10.1016/j.cgh.2006.05.017.
11. Masamune A, Nishimori I, Kikuta K, et al. Research Committee of Intractable Pancreas Diseases in Japan. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut 2017;66(3):487–494. doi:10.1136/gutjnl- -2016-312049.
12. Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2013;62(11):1607–1615. doi:10.1136/gutjnl- 2012-302886.
13. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010;139(1):140– 148. doi:10.1053/j.gastro.2010.03.054.
14. Scholten L, Latenstein AEJ, van Eijck C, et al. Dutch Pancreatic Cancer Group. Outcome and long-term quality of life after total pancreatectomy (PANORAMA): a nationwide cohort study. Surgery 2019;166(6):1017–1026. doi:10.1016/j. surg.2019.07.025.
15. Yu T, Wu Y, Liu J, et al. The risk of malignancy in patients with IgG4-related disease: a systematic review and metaanalysis. Arthritis Res Ther. 2022;24(1):14. doi:10.1186/s13075-021-02652-2.
Štítky
Surgery Orthopaedics Trauma surgeryČlánok vyšiel v časopise
Perspectives in Surgery
2022 Číslo 11
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Současný stav chirurgické léčby chronické pankreatitidy v České republice
- Latex and silicone drains in surgery − is the ban on rubber drains really a step forward or rather a step back?
- Pancreatic cancer in chronic pancreatitis – the diagnostic and therapeutic dilemma; an overview of cases
- Historical overview of surgical procedures for chronic pancreatitis